查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132249

冠狀動脈藥物塗層球囊導管市場規模、佔有率和趨勢分析報告：按適應症、藥物類型、最終用途、地區和細分市場預測（2026-2033 年）

Coronary Drug-Coated Balloon Catheter Market Size, Share & Trends Analysis Report By Indication, By Drug Type, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

冠狀動脈藥物塗層球囊導管市場概述

全球冠狀動脈藥物塗層球囊導管市場預計到 2025 年將達到 3.424 億美元，從 2026 年的 3.749 億美元成長到 2033 年的 7.272 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 9.9%。

北美市場主導，預計到 2025 年將佔據 44.1% 的市佔率。全球經皮冠狀動脈介入治療 (PCI) 手術的增加推動了對冠狀動脈藥物釋放型球囊導管的需求，尤其是在治療支架內血管再阻塞和複雜冠狀動脈病變方面。

此外，美國、德國和日本等國家擴大了冠狀動脈介入治療的綜合保險覆蓋範圍，改善了患者的就醫途徑，並加速了藥物塗層球囊技術的應用。

市場動態

冠狀動脈疾病（CAD）盛行率的上升、經皮冠狀動脈介入治療（PCI）手術量的增加以及微創冠狀動脈重組術的日益普及，正在推動冠狀動脈藥物釋放型球囊導管市場的成長。支架內血管再阻塞（ISR）、微血管疾病和複雜冠狀動脈病變的發生率不斷上升，加速了有效替代支架植入術的需求。藥物塗層技術的不斷進步，特別是新一代Sirolimus塗層球囊的研發，以及不斷成長的臨床證據和有利的法規核准，進一步提升了市場滲透率。

然而，嚴格的法規核准要求、強制性的大規模臨床試驗以及先進介入手術的高成本仍然限制市場成長。創新技術的商業化進程不斷推進、醫生對「零浪費」治療策略的日益青睞以及新興醫療市場應用範圍的擴大，預計將在預測期內創造顯著的成長機會。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 冠狀動脈藥物塗層球囊導管市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 冠狀動脈藥物塗層球囊導管市場分析工具
  • 各國市場促進因素分析（冠狀動脈藥物塗層球囊）
  • 創新和產品開發分析
  • 市場進入吸引力評估

第4章 冠狀動脈藥物塗層球囊導管市場：依適應症分類的估算與趨勢分析

  • 按適應症分類的市場佔有率，2025 年和 2033 年
  • 冠狀動脈藥物塗層球囊導管市場：依適應症分類的展望
  • 支架內血管再阻塞（ISR）
  • 新冠狀動脈病變
  • 複雜/複雜的冠狀動脈病變

第5章 冠狀動脈藥物塗層球囊導管市場：依技術整合方式進行的估算與趨勢分析

  • 按藥物類型分類的市場佔有率，2025 年和 2033 年
  • 冠狀動脈藥物塗層球囊導管市場：按藥物類型分類的展望
  • 紫杉醇
  • Sirolimus
  • 其他

第6章 冠狀動脈藥物塗層球囊導管市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市場佔有率，2025 年和 2033 年
  • 冠狀動脈藥物塗層球囊導管市場：依最終用途分類的展望
  • 電子醫院
  • 專科心血管中心
  • 門診手術中心（ASC）

第7章 冠狀動脈藥物塗層球囊導管市場：按適應症、藥物類型和最終用途分類的區域估算和趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 印尼
    • 馬來西亞
    • 越南
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
  • 主要公司市佔率分析，2025 年（%）
  • 公司列表
    • Boston Scientific
    • Lepu Medical
    • Medtronic
    • B. Braun SE
    • Concept Medical
    • Teleflex Incorporated（BIOTRONIK）
    • MicroPort Scientific Corporation
    • iVascular SLU
Product Code: GVR-4-68040-934-1

Coronary Drug-Coated Balloon Catheter Market Summary

The global coronary drug-coated balloon catheter market size was valued at USD 342.4 million in 2025 and is projected to grow from USD 374.9 million in 2026 to USD 727.2 million by 2033, at a CAGR of 9.9% from 2026 to 2033. North America dominated the market, accounting for a share of 44.1% in 2025. Increasing Percutaneous Coronary Intervention (PCI) volumes globally are driving the demand for coronary drug-coated balloon catheters, particularly for treating in-stent restenosis and complex coronary lesions.

In addition, comprehensive reimbursement coverage for coronary interventions in countries such as the U.S., Germany, and Japan is improving patient access and accelerating the adoption of drug-coated balloon technologies.

Market Dynamic

The rising prevalence of coronary artery disease (CAD), increasing volumes of PCI procedures, and growing adoption of minimally invasive coronary revascularization techniques are driving the growth of the coronary drug-coated balloon catheter market. Increasing incidences of in-stent restenosis (ISR), small vessel disease, and complex coronary lesions are accelerating the demand for an effective alternative to repeat stenting. Continuous advancements in drug-coating technologies, particularly the development of next-generation sirolimus-coated balloons, along with expanding clinical evidence and favorable regulatory approvals, are further supporting market adoption.

However, stringent regulatory approval requirements, extensive clinical trial obligations, and the high cost of advanced interventional procedures continue to restrain market growth. Expanding commercialization of innovative technologies, increasing physician preference for "leave nothing behind" treatment strategies, and growing adoption across emerging healthcare markets are expected to create significant growth opportunities during the forecast period.

Global Coronary Drug-Coated Balloon Catheter Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels, and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global coronary drug-coated balloon catheter market report on the basis of indication, drug type, end use, and region:

  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • In-Stent Restenosis (ISR)
  • De-novo coronary lesions
  • Complex / Adjunct Coronary Lesions
  • Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Paclitaxel
  • Sirolimus
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Cardiac/Vascular Centers
  • Ambulatory Surgical Centers (ASCs)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • Australia
    • India
  • South Korea
    • Thailand
    • Indonesia
    • Malaysia
    • Vietnam
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Indication
    • 1.1.2. Drug Type
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Indication outlook
    • 2.2.2. Drug type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary Drug-Coated Balloon Catheters Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. Coronary Drug-Coated Balloon Catheters Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape
  • 3.4. Country-Level Market Driver Mapping (Coronary DCB)
    • 3.4.1. Regulatory Landscape Influencing the Coronary Drug-Coated Balloon Market Dynamics
    • 3.4.2. Clinical Trial Presence in Major Countries
    • 3.4.3. Global Distribution Footprint
    • 3.4.4. Pricing Competitiveness
  • 3.5. Innovation & Product Development Analysis
    • 3.5.1. New Product Launches
    • 3.5.2. Product Pipeline
    • 3.5.3. Emerging Coating Technologies
  • 3.6. Market Entry Attractiveness Assessment

Chapter 4. Coronary Drug-Coated Balloon Catheters Market: Indication Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Indication Market Share, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Coronary Drug-Coated Balloon Catheters Market by Indication Area Outlook
  • 4.5. In-Stent Restenosis (ISR)
    • 4.5.1. In-stent restenosis (ISR) market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.6. De-novo Coronary Lesions
    • 4.6.1. De-novo coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)
  • 4.7. Complex / Adjunct Coronary Lesions
    • 4.7.1. Complex / adjunct coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 5. Coronary Drug-Coated Balloon Catheters Market: Technology Integration Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Drug Type Market Share, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Coronary Drug-Coated Balloon Catheters Market by Drug Type Outlook
  • 5.5. Paclitaxel
    • 5.5.1. Paclitaxel market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.6. Sirolimus
    • 5.6.1. Sirolimus market estimates and forecast, 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 6. Coronary Drug-Coated Balloon Catheters Market: End Use Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Coronary Drug-Coated Balloon Catheters Market by End Use Outlook
  • 6.5. E- Hospitals
    • 6.5.1. Hospitals market estimates and forecast, 2021 to 2033 (USD Million)
  • 6.6. Specialty Cardiac/Vascular Centers
    • 6.6.1. Specialty cardiac/vascular centers market estimates and forecast, 2021 to 2033 (USD Million)
  • 6.7. Ambulatory Surgical Centers (ASCs)
    • 6.7.1. Ambulatory surgical centers (ASCs) market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 7. Coronary Drug-Coated Balloon Catheters Market: Regional Estimates & Trend Analysis, By Indication, By Drug Type, By End Use

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.4.1.5. U.S. market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.4.2.5. Canada market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.4.3.5. Mexico market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.5.1.5. UK market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.5.2.5. Germany market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.5.3.5. France market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.5.4.5. Italy market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.5.5.5. Spain market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.5.6.5. Norway market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.5.7.5. Sweden market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.5.8.5. Denmark market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.1.5. Japan market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.2.5. China market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.3.5. India market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.4.5. Australia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.5.5. South Korea market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.6.5. Thailand market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.6.7. Indonesia
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Indonesia market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.7.5. Indonesia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.6.8. Malaysia
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.8.5. Malaysia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.6.9. Vietnam
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Vietnam market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.6.9.5. Vietnam market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.7.1.5. Brazil market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.7.2.5. Argentina market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.7.3. Colombia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Colombia market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.7.3.5. Colombia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.7.4. Chile
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Chile market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.7.4.5. Chile market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.8.1.5. South Africa market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.8.2.5. Saudi Arabia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.8.3.5. UAE market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
      • 7.8.4.5. Kuwait market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000' Units)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key Company Market Share Analysis, 2025 (%)
  • 8.4. List of Companies
    • 8.4.1. Boston Scientific
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Lepu Medical
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Medtronic
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. B. Braun SE
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Concept Medical
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Teleflex Incorporated (BIOTRONIK)
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. MicroPort Scientific Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. iVascular S.L.U.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 4 North America coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 5 North America coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 6 North America coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
  • Table 7 U.S. coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 8 U.S. coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 9 U.S. coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 10 Canada coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 11 Canada coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 12 Canada coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 13 Mexico coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 14 Mexico coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 15 Mexico coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 16 Europe coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 17 Europe coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 18 Europe coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 19 Europe coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
  • Table 20 UK coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 21 UK coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 22 UK coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 23 Germany coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 24 Germany coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 25 Germany coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 26 France coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 27 France coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 28 France coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 29 Italy coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 30 Italy coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 31 Italy coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 32 Spain coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 33 Spain coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 34 Spain coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 35 Denmark coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 36 Denmark coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 37 Denmark coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 38 Sweden coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 39 Sweden coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 40 Sweden coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 41 Norway coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 42 Norway coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 43 Norway coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
  • Table 48 China coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 49 China coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 50 China coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 51 Japan coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 52 Japan coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 53 Japan coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 54 India coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 55 India coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 56 India coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 57 Australia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 58 Australia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 59 Australia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 60 South Korea coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 61 South Korea coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 62 South Korea coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 63 Thailand coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 64 Thailand coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 65 Thailand coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 66 Indonesia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 67 Indonesia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 68 Indonesia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 69 Malaysia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 70 Malaysia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 71 Malaysia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 72 Vietnam coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 73 Vietnam coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 74 Vietnam coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 75 Latin America coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 76 Latin America coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 77 Latin America coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 78 Latin America coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
  • Table 79 Brazil coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 80 Brazil coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 81 Brazil coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 82 Argentina coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 83 Argentina coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 84 Argentina coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 85 Colombia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 86 Colombia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 87 Colombia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 88 Chile coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 89 Chile coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 90 Chile coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 91 MEA coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 92 MEA coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 93 MEA coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 94 MEA coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
  • Table 95 South Africa coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 96 South Africa coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 97 South Africa coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 98 Saudi Arabia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 99 Saudi Arabia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 100 Saudi Arabia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 101 UAE coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 102 UAE coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 103 UAE coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
  • Table 104 Kuwait coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
  • Table 105 Kuwait coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
  • Table 106 Kuwait coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Coronary drug-coated balloon catheter: Market outlook
  • Fig. 9 Coronary drug-coated balloon catheter: Competitive Insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Coronary drug-coated balloon catheter market driver impact
  • Fig. 15 Coronary drug-coated balloon catheter market restraint impact
  • Fig. 16 Coronary drug-coated balloon catheter market strategic initiative
  • Fig. 17 Coronary drug-coated balloon catheter market: Indication movement
  • Fig. 18 Coronary drug-coated balloon catheter market: Indication outlook
  • Fig. 19 In-stent restenosis (ISR) market estimates and forecasts, 2021 - 2033
  • Fig. 20 De-novo coronary lesions market estimates and forecasts, 2021 - 2033
  • Fig. 21 Complex / adjunct coronary lesions market estimates and forecasts, 2021 - 2033
  • Fig. 22 Coronary drug-coated balloon catheter market: Drug type movement
  • Fig. 23 Coronary drug-coated balloon catheter market: Drug type outlook
  • Fig. 24 Paclitaxel market estimates and forecasts, 2021 - 2033
  • Fig. 25 Sirolimus market estimates and forecasts, 2021 - 203
  • Fig. 26 Others market estimates and forecasts, 2021 - 2033
  • Fig. 27 Coronary drug-coated balloon catheter market: End use movement
  • Fig. 28 Coronary drug-coated balloon catheter market: End use outlook
  • Fig. 29 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 30 Specialty cardiac/vascular centers market estimates and forecasts, 2021 - 203
  • Fig. 31 Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 - 2033
  • Fig. 32 Coronary drug-coated balloon catheter market: Regional
  • Fig. 33 Coronary drug-coated balloon catheter market: Regional
  • Fig. 34 North America market estimates and forecasts, 2021 - 2033
  • Fig. 35 US market estimates and forecasts, 2021 - 2033
  • Fig. 36 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 37 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 38 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 39 UK market estimates and forecasts, 2021 - 2033
  • Fig. 40 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 41 France market estimates and forecasts, 2021 - 2033
  • Fig. 42 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 43 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 44 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 45 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 46 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 47 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 48 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 49 China market estimates and forecasts, 2021 - 2033
  • Fig. 50 India market estimates and forecasts, 2021 - 2033
  • Fig. 51 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 52 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 53 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 54 Indonesia market estimates and forecasts, 2021 - 2033
  • Fig. 55 Malaysia market estimates and forecasts, 2021 - 2033
  • Fig. 56 Vietnam market estimates and forecasts, 2021 - 2033
  • Fig. 57 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 58 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 59 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 60 Colombia market estimates and forecasts, 2021 - 2033
  • Fig. 61 Chile market estimates and forecasts, 2021 - 2033
  • Fig. 62 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 64 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 65 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 66 Kuwait market estimates and forecasts, 2021 - 2033